Skip to content
Cohance Lifesciences
Home
About
Our Company
Vision and Values
Board of Directors
Management Committee
Corporate Information
Business Units
CDMO
API and Formulations
Clinical research & Bio Analytical Studies
Research and Development
Infrastructure
Overview
Manufacturing Units
API Unit I – Jaggayapet
API Unit II – Atchutapuram
API Unit III – Ankaleshwar
API Unit IV – Nacharam
API Unit V – Parwada, Vizag
FDF/PFI Unit I – Nacharam
FDF/PFI Unit II – Jadcherla
R&D
API R&D Unit I – Patancheru
API R&D Unit II – Ankaleshwar
API R&D Unit III – Nacharam
FDF R&D Unit I – Nacharam
Clinical Research and Bio Analytical Studies
CRBio – Balanagar
Sustainability
EHS
CSR
Governance
Life at Cohance
We are Cohancers
Cohance with Us
Gallery
Investors
Media
Press release/announcement
Media coverage
Contact
Home
About
Our Company
Vision and Values
Board of Directors
Management Committee
Corporate Information
Business Units
CDMO
API and Formulations
Clinical research & Bio Analytical Studies
Research and Development
Infrastructure
Overview
Manufacturing Units
API Unit I – Jaggayapet
API Unit II – Atchutapuram
API Unit III – Ankaleshwar
API Unit IV – Nacharam
API Unit V – Parwada, Vizag
FDF/PFI Unit I – Nacharam
FDF/PFI Unit II – Jadcherla
R&D
API R&D Unit I – Patancheru
API R&D Unit II – Ankaleshwar
API R&D Unit III – Nacharam
FDF R&D Unit I – Nacharam
Clinical Research and Bio Analytical Studies
CRBio – Balanagar
Sustainability
EHS
CSR
Governance
Life at Cohance
We are Cohancers
Cohance with Us
Gallery
Investors
Media
Press release/announcement
Media coverage
Contact
Investors
You are here:
Home
Investors
Investors Presentation
H1 FY 25
Q1 FY 25
FY 24
Q3 FY 24
H1 FY24
June 2023
March 2023
December 2022
Corporate Governance
Notice of NCLT Convened meeting
Newspaper Advertisement
Notice of AGM for FY 2022-23
Notices sent to Statutory Authorities
Scheme - Merger of ZCL and Avra with Cohance
Go to Top